These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [WILSON'S DISEASE IN THE FORM OF A PANHEMOCYTOPENIA]. HEINRICH F; KALTENBACH M Med Klin; 1965 Mar; 60():499-502. PubMed ID: 14266590 [No Abstract] [Full Text] [Related]
6. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine. GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF Trans Am Neurol Assoc; 1961; 86():131-4. PubMed ID: 13899919 [No Abstract] [Full Text] [Related]
7. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine]. Germinario L; Campanella G; D'Addabbo A Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824 [No Abstract] [Full Text] [Related]
8. WILSON'S DISEASE PRESENTING AS AN ACUTE HAEMOLYTIC ANAEMIA. LAURANCE BM Proc R Soc Med; 1965 Aug; 58(8):614-5. PubMed ID: 14341840 [No Abstract] [Full Text] [Related]
10. [CURRENT ASPECTS OF WILSON'S DISEASE]. PETIT H Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920 [No Abstract] [Full Text] [Related]
11. TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE. TU JB; COOPER WC; BLACKWELL RQ; HOU TY Neurology; 1965 Apr; 15():402-8. PubMed ID: 14280605 [No Abstract] [Full Text] [Related]
12. [The use of penicillamine as a diagnostic aid in hepatolenticular degeneration (Wilson's disease)]. BLEHOVA B; HEYROVSKY L Cesk Pediatr; 1961 Sep; 16():809-11. PubMed ID: 13869965 [No Abstract] [Full Text] [Related]
13. COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE. GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF Arch Neurol; 1965 May; 12():456-62. PubMed ID: 14288982 [No Abstract] [Full Text] [Related]
14. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823 [TBL] [Abstract][Full Text] [Related]
15. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease]. Storch W; Berger H Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606 [TBL] [Abstract][Full Text] [Related]
17. [On Wilson's disease. Also a contribution on penicillamine therapy]. LANGE J; HAGER H Z Kinderheilkd; 1960; 84():125-36. PubMed ID: 13853564 [No Abstract] [Full Text] [Related]
18. [IMPROVEMENT IN WILSON'S DISEASE IN A 17-YEAR-OLD GIRL WITH CONTINUOUS PENICILLAMINE THERAPY]. LISA L; ROESSLER M; HEYROVSKY A Cesk Pediatr; 1964 Oct; 19():908-11. PubMed ID: 14216172 [No Abstract] [Full Text] [Related]
19. Treatment of Wilson's disease with penicillamine. WALSHE JM Lancet; 1960 Jan; 1(7117):188-92. PubMed ID: 13842679 [No Abstract] [Full Text] [Related]
20. Membranoproliferative glomerulonephritis in a patient with Wilson's disease. Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]